CRM
65
6
LH
33
3
EW
55
5
DOV
48
2
V
70
14
BF.B
35
2
LRCX
56
4
SBUX
29
-2
CHRW
53
2
MO
47
6
EXR
42
5
ILMN
31
4
KLAC
45
3
VFC
56
6
EBAY
42
2
CI
35
2
NWS
69
5
VRSK
54
2
MA
60
5
LEG
16
2
CRM
65
6
LH
33
3
EW
55
5
DOV
48
2
V
70
14
BF.B
35
2
LRCX
56
4
SBUX
29
-2
CHRW
53
2
MO
47
6
EXR
42
5
ILMN
31
4
KLAC
45
3
VFC
56
6
EBAY
42
2
CI
35
2
NWS
69
5
VRSK
54
2
MA
60
5
LEG
16
2
Financhill
Back

Lifecore Biomedical 10K Form

Buy
54

LFCR
Lifecore Biomedical

Last Price:
$7.22
Seasonality Move:
6.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LFCR News And Ratings

See the #1 stock for the next 7 days that we like better than LFCR

LFCR Financial Statistics

Sales & Book Value

Annual Sales: $128.3M
Cash Flow: $6M
Price / Cash Flow: 0
Annual Sales: $0.37
Price / Book: 15.52

Profitability

EPS (TTM): 0.23000
Net Income (TTM): $12M
Gross Margin: $41.9M
Return on Equity: 475.5%
Return on Assets: 4.82%

Lifecore Biomedical Earnings Forecast

Key Lifecore Biomedical Financial Ratios

  • The Gross Profit Margin over the past 29 years for LFCR is 32.63%.
  • The Selling, General & Administrative Expenses for LFCR have been equal to 31.55% of Gross Profit Margin.
  • The Research & Development expenses have been 6.69% of Revenue.
  • The Interest Expense is 150.59% of Operating Income.
  • The Net Earning history of LFCR is 9.37% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

Lifecore Biomedical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: LFCR
Website: lifecore.com

Debt

Debt-to-Equity Ratio: 10.72
Current Ratio: 2.08
Quick Ratio: 1.02

Price-to-Earnings

Trailing P/E Ratio: 22.59
Forward P/E Ratio: 0

LFCR Technical Analysis vs Fundamental Analysis

Buy
54
Lifecore Biomedical (LFCR) is a Buy

Is Lifecore Biomedical a Buy or a Sell?